Technologies

time icon Feb. 1, 2012

Novel Treatment of Glaucoma

Technology description

Use of A3 Subtype Adenosine-Receptor Antagonists to Treat Glaucoma

Description

Glaucoma affects an estimated three million people in the United States, with 300,000 new cases diagnosed every year. It is a major cause of human blindness and is usually associated with an elevation of pressure in the eye.

由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。

More information

Categories
  • Diagnosis and treatment
  • Ophthalmology

下载 PDF 文档


感兴趣

Contact us

知繁业茂-yintrust logo知繁业茂-Branchly Innovation logo 知繁业茂-autmasia logo迈科技 logo